{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:27:12Z","timestamp":1761182832356,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2001]]},"DOI":"10.1007\/s101560100020","type":"journal-article","created":{"date-parts":[[2002,10,15]],"date-time":"2002-10-15T10:53:15Z","timestamp":1034679195000},"page":"121-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of in-vitro activities of SCH27899 and other antibiotics against Mycoplasma pneumoniae"],"prefix":"10.1016","volume":"7","author":[{"given":"Hideaki","family":"Ikejima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigemi","family":"Terakubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingoro","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s101560100020_bib0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/infdis\/139.6.681","article-title":"Long-term epidemiology of infections with Mycoplasma pneumoniae","volume":"139","author":"Foy","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1007\/s101560100020_bib0010","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/AAC.36.6.1322","article-title":"Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae","volume":"36","author":"Arai","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s101560100020_bib0015","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/AAC.38.4.790","article-title":"In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae","volume":"38","author":"Ishida","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s101560100020_bib0020","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/AAC.33.9.1419","article-title":"New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy","volume":"33","author":"Kirst","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s101560100020_bib0025","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.32.10.1500","article-title":"In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones","volume":"32","author":"Waites","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s101560100020_bib0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/AAC.37.2.287","article-title":"Effects of new quinolones on Mycoplasma pneumoniae infected hamsters","volume":"37","author":"Arai","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s101560100020_bib0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jac\/34.6.875","article-title":"In-vitro and in-vivo activities of a new quinolone AM-1155 against Mycoplasma pneumoniae","volume":"34","author":"Ishida","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s101560100020_bib0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/AAC.35.3.587","article-title":"Susceptibility of Mycoplasma pneumoniae to several new quinolines, tetracycline, and erythromycin","volume":"35","author":"Kenny","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s101560100020_bib0045","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jac\/40.5.622","article-title":"Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections","volume":"40","author":"Taylor-Robinson","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s101560100020_bib0050","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/AAC.44.3.732-738.2000","article-title":"Mutations in ribosomal protein L16 conferring reduced susceptibility to everninomicin (SCH27899): implications for mechanism of action","volume":"44","author":"Adrian","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s101560100020_bib0055","first-page":"7","article-title":"Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity","volume":"21","author":"Nakashio","year":"1995","journal-title":"Drugs Exp Clin Res"},{"key":"10.1007\/s101560100020_bib0060","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1128\/jb.171.12.6455-6467.1989","article-title":"A phylogenetic analysis of the mycoplasmas: basis for their classification","volume":"171","author":"Weisburg","year":"1989","journal-title":"J Bacteriol"},{"key":"10.1007\/s101560100020_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1073\/pnas.48.1.41","article-title":"Growth on artificial medium of an agent associated with atypical pneumonia and its identification as PPLO","volume":"48","author":"Chanock","year":"1962","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s101560100020_bib0070","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/archinte.1970.00310040104012","article-title":"Comparison of antibiotics in the treatment of Mycoplasmal pneumonia","volume":"125","author":"Shames","year":"1970","journal-title":"Arch Int Med"},{"key":"10.1007\/s101560100020_bib0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/jac\/37.2.361","article-title":"Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin","volume":"37","author":"Urban","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s101560100020_bib0080","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1093\/nar\/24.22.4420","article-title":"Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae","volume":"24","author":"Himmelreich","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"10.1007\/s101560100020_bib0085","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1128\/jb.174.22.7289-7296.1992","article-title":"Construction of an EcoRI restriction map of Mycoplasma pneumoniae and localization of selected genes","volume":"174","author":"Wenzel","year":"1992","journal-title":"J Bacteriol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X01712809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X01712809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s101560100020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:42:37Z","timestamp":1761158557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X01712809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001]]}},"alternative-id":["S1341321X01712809"],"URL":"https:\/\/doi.org\/10.1007\/s101560100020","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2001]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of in-vitro activities of SCH27899 and other antibiotics against Mycoplasma pneumoniae","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s101560100020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}